Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Pigment Cell & Melanoma Research
|
April 11, 2020
Emerging strategies to treat rare and intractable subtypes of melanoma
Gretchen M Alicea, Vito W Rebecca
Biochemical Pharmacology
|
August 10, 2014
Change or die: targeting adaptive signaling to kinase inhibition in cancer cells
Vito W Rebecca, Keiran S M Smalley
Journal of the National Medical Association
|
September 12, 2021
Genetic characteristics and response to systemic therapies of acral lentiginous melanoma at a tertiary care center-a retrospective review
Taylor Jamerson, Vito W Rebecca, Crystal Aguh
Nature Communications
|
June 7, 2020
Pre-clinical modeling of cutaneous melanoma
Vito W Rebecca, Rajasekharan Somasundaram, Meenhard Herlyn
Journal of Visualized Experiments : Jove
|
June 4, 2019
A Melanoma Patient-Derived Xenograft Model
Min Xiao, Vito W Rebecca, Meenhard Herlyn
Pigment Cell & Melanoma Research
|
September 28, 2023
Brief history of the Society for Melanoma Research: A community of clinicians, researchers, and friends
Vito W Rebecca, Jessie Villanueva, Marie R Webster
Melanoma Research
|
March 8, 2012
A brief history of melanoma: from mummies to mutations
Vito W Rebecca, Vernon K Sondak, Keiran S M Smalley
Pigment Cell & Melanoma Research
|
October 11, 2023
Progress in melanoma treatment: Patient's perspectives
Gretchen M Alicea, Jessie Villanueva, Marie R Webster, et al.
Pigment Cell & Melanoma Research
|
May 12, 2023
Undereducation is afoot: Assessing the lack of acral lentiginous melanoma educational materials for skin of color
Vissy M Elad, Trevena Anton, Natalie C Ganios, et al.
Nature Cancer
|
July 17, 2024
Determinants of resistance and response to melanoma therapy
Bailey M Robertson, Mitchell E Fane, Ashani T Weeraratna, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Pigment Cell & Melanoma Research
|
April 11, 2020
Emerging strategies to treat rare and intractable subtypes of melanoma
Gretchen M Alicea, Vito W Rebecca
Biochemical Pharmacology
|
August 10, 2014
Change or die: targeting adaptive signaling to kinase inhibition in cancer cells
Vito W Rebecca, Keiran S M Smalley
Journal of the National Medical Association
|
September 12, 2021
Genetic characteristics and response to systemic therapies of acral lentiginous melanoma at a tertiary care center-a retrospective review
Taylor Jamerson, Vito W Rebecca, Crystal Aguh
Nature Communications
|
June 7, 2020
Pre-clinical modeling of cutaneous melanoma
Vito W Rebecca, Rajasekharan Somasundaram, Meenhard Herlyn
Journal of Visualized Experiments : Jove
|
June 4, 2019
A Melanoma Patient-Derived Xenograft Model
Min Xiao, Vito W Rebecca, Meenhard Herlyn
Pigment Cell & Melanoma Research
|
September 28, 2023
Brief history of the Society for Melanoma Research: A community of clinicians, researchers, and friends
Vito W Rebecca, Jessie Villanueva, Marie R Webster
Melanoma Research
|
March 8, 2012
A brief history of melanoma: from mummies to mutations
Vito W Rebecca, Vernon K Sondak, Keiran S M Smalley
Pigment Cell & Melanoma Research
|
October 11, 2023
Progress in melanoma treatment: Patient's perspectives
Gretchen M Alicea, Jessie Villanueva, Marie R Webster, et al.
Pigment Cell & Melanoma Research
|
May 12, 2023
Undereducation is afoot: Assessing the lack of acral lentiginous melanoma educational materials for skin of color
Vissy M Elad, Trevena Anton, Natalie C Ganios, et al.
Nature Cancer
|
July 17, 2024
Determinants of resistance and response to melanoma therapy
Bailey M Robertson, Mitchell E Fane, Ashani T Weeraratna, et al.
Page
of 6